Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer. [electronic resource]
Producer: 20170613Description: 1215-1220 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease-Free Survival
- Drug Combinations
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Oxonic Acid -- administration & dosage
- Prospective Studies
- Tegafur -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.